140 related articles for article (PubMed ID: 1690316)
1. Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations.
Visscher DW; Zarbo RJ; Jacobsen G; Kambouris A; Talpos G; Sakr W; Crissman JD
Lab Invest; 1990 Mar; 62(3):370-8. PubMed ID: 1690316
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
[TBL] [Abstract][Full Text] [Related]
4. Assessment and significance of diploid-range epithelial populations in DNA aneuploid breast carcinomas using multi-parametric flow cytometry.
Visscher DW; Sochacki P; Ottosen S; Wykes S; Crissman JD
Anal Cell Pathol; 1995 Jun; 8(4):267-77. PubMed ID: 7577742
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric evaluation of flow cytometric synthesis phase fraction determination in dual-labelled breast carcinomas.
Visscher DW; Wykes S; Zarbo RJ; Crissman JD
Anal Quant Cytol Histol; 1991 Aug; 13(4):246-52. PubMed ID: 1718294
[TBL] [Abstract][Full Text] [Related]
6. Automated peak detection and cell cycle analysis of flow cytometric DNA histograms.
Kallioniemi OP; Visakorpi T; Holli K; Isola JJ; Rabinovitch PS
Cytometry; 1994 Jul; 16(3):250-5. PubMed ID: 7924694
[TBL] [Abstract][Full Text] [Related]
7. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
Prasad AR; Divine G; Zarbo RJ
Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
9. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F
Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
[TBL] [Abstract][Full Text] [Related]
10. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.
Hedley DW; Rugg CA; Gelber RD
Cancer Res; 1987 Sep; 47(17):4729-35. PubMed ID: 3621170
[TBL] [Abstract][Full Text] [Related]
11. DNA analysis and S-phase fraction determination by flow cytometric analysis of infiltrating lobular carcinoma of the breast.
Frost AR; Karcher DS; Terahata S; Siegel RS; Silverberg SG
Mod Pathol; 1996 Sep; 9(9):930-7. PubMed ID: 8878026
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of flow cytometry for metastatic potential in breast cancer.
Schmidt H; Wei JP; Yeh KA
Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
[TBL] [Abstract][Full Text] [Related]
13. Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry.
Lee AK; Wiley B; Dugan JM; Hamilton WH; Loda M; Heatley GJ; Cook L; Silverman ML
Pathol Res Pract; 1992 Jun; 188(4-5):428-32. PubMed ID: 1329051
[TBL] [Abstract][Full Text] [Related]
14. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.
Dabbs DJ
Mod Pathol; 1995 Aug; 8(6):637-42. PubMed ID: 8532697
[TBL] [Abstract][Full Text] [Related]
15. Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group.
Baldetorp B; Stål O; Ahrens O; Cornelisse C; Corver W; Falkmer U; Fernö M
Cytometry; 1998 Dec; 33(4):385-93. PubMed ID: 9845432
[TBL] [Abstract][Full Text] [Related]
16. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
17. The S-phase fraction of the aneuploid cell subpopulation is the biologically relevant one in aneuploid breast cancers.
Martinez-Arribas F; Nuñez-Villar MJ; Lucas AR; Sanchez J; Tejerina A; Schneider J
Breast Cancer Res Treat; 2005 Jul; 92(1):77-80. PubMed ID: 15980994
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle analysis of normal, atrophic, and hyperplastic breast epithelium using two-color multiparametric flow cytometry.
Visscher DW; Gingrich DS; Buckley J; Tabaczka P; Crissman JD
Anal Cell Pathol; 1996 Nov; 12(2):115-24. PubMed ID: 8986295
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric enumeration and kinetic analysis of inflammatory cell populations in breast carcinomas.
Visscher DW; VanBree G; Ottosen S; Wykes S; Crissman JD
Anal Cell Pathol; 1993 Nov; 5(6):321-30. PubMed ID: 8305328
[TBL] [Abstract][Full Text] [Related]
20. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
